Adeno-associated virus-coated allografts: a novel approach for cranioplasty

Bone autografts are considered the gold standard for cranioplasty, although they lead to co‐morbidity. Bone allografts are more easily obtained but have low osteogenic potential and fail to integrate into healthy bone. Previously, we showed that, by coating long‐bone allografts with freeze‐dried rec...

Full description

Saved in:
Bibliographic Details
Published inJournal of tissue engineering and regenerative medicine Vol. 6; no. 10; pp. e43 - e50
Main Authors Ben Arav, Ayelet, Pelled, Gadi, Zilberman, Yoram, Kimelman-Bleich, Nadav, Gazit, Zulma, Schwarz, Edward M., Gazit, Dan
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.11.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bone autografts are considered the gold standard for cranioplasty, although they lead to co‐morbidity. Bone allografts are more easily obtained but have low osteogenic potential and fail to integrate into healthy bone. Previously, we showed that, by coating long‐bone allografts with freeze‐dried recombinant adeno‐associated virus (rAAV) vector encoding for an osteogenic gene, enhanced osteogenesis and bone integration were achieved. In this study our aim was to evaluate the bone repair potential of calvarial autografts and allografts coated with either single‐stranded rAAV2 vector (SS‐rAAV‐BMP2) or self‐complementary pseudotyped vector (SC‐rAAV‐BMP2) encoding for bone morphogenetic protein (BMP)2 in a murine cranioplasty model. The grafts were implanted into critical defects in the calvariae of osteocalcin/luciferase (Oc/Luc) transgenic mice, which allowed longitudinal monitoring of osteogenic activity using bioluminescence imaging (BLI). Our results showed that the bioluminescent signal of the SC‐rAAV‐BMP2‐coated allografts was 40% greater than that of the SS‐rAAV‐BMP2‐coated allografts (p < 0.05) and that the bioluminescent signal of the SS‐rAAV‐BMP2‐coated allografts was not significantly different from the signals of the autografts or uncoated allografts. Micro‐computed tomography (μCT) confirmed the significant increase in osteogenesis in the SC‐rAAV‐BMP2 group compared with the SS‐rAAV‐BMP2 group (p < 0.05), indicating a significant difference in bone formation when compared with the other grafts tested. In addition, histological analysis revealed extensive remodelling of the autografts. Collectively, these results demonstrate the feasibility of craniofacial regeneration using SC‐rAAV‐BMP2‐coated allografts, which may be an attractive therapeutic solution for repair of severe craniofacial bone defects. Copyright © 2012 John Wiley & Sons, Ltd.
Bibliography:ArticleID:TERM1594
National Institutes of Health - No. R21DE017096; No. R01DE019902; No. AR46545; No. AR54884; No. AR54041
istex:A9CACCBC67BA6573AD42F9A97F08C481BE2840DC
ark:/67375/WNG-J44GCQK8-J
These authors contributed equally to this study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Equal contribution.
ISSN:1932-6254
1932-7005
DOI:10.1002/term.1594